Alexandria Real Estate Equities has secured a future long-term headquarters for Eikon Therapeutics. The new HQ will be in the Millbrae Offices and Life Sciences campus, currently under construction across from the Millbrae Train Station. The company will be moving to San Mateo County from its current location in Hayward.
The entitlement application is under review to replace a two-story office building with a nearly identically-sized project at 901 South California Avenue in Palo Alto, Santa Clara County. The property is within the Stanford Research Park, across from the College Terraces neighborhood. Alexandria Real Estate Equities is responsible for the application.
New renderings have been revealed for the proposed life sciences campus in Millbrae, San Mateo County. The project will add over half a million square feet with space for over two thousand employees, across from the mixed-use Gateway at Millbrae Station development. Greystar is partnering with Alexandria Real Estate Equities, a major investor in biotech projects across the nation.
Construction has topped out for the new R&D office building at 751 Gateway Boulevard in South San Francisco. The project has replaced a large surface parking lot in the city center, expanding the Gateway Campus owned by Alexandria Real Estate Equities and Boston Properties. The development is a joint venture between the two developers.
The City Planning Commission has approved amended plans for a new life sciences research building for 1450 Owens Street in Mission Bay, San Francisco. The approved project will bring over 175,000 square feet onto the 1.13-acre lot, rising 109 feet above street level. The busy Alexandria Real Estate Equities (ARE), the largest real estate investment trust (REIT) for life science real estate in the USA, is responsible for the development.
